Exploring HIV infection in a UK vulnerable prisoner population in response to newly identified cases

Date29 August 2019
Pages244-249
DOIhttps://doi.org/10.1108/IJPH-03-2018-0010
Published date29 August 2019
AuthorStephanie E. Perrett,Thomas D. Waite
Subject MatterHealth & social care,Criminology & forensic psychology,Prisoner health,Sociology,Sociology of crime & law,Public policy & environmental management,Policing,Criminal justice
Exploring HIV infection in a UK vulnerable
prisoner population in response to newly
identified cases
Stephanie E. Perrett and Thomas D. Waite
Abstract
Purpose Prison populations are considered at elevated risk of blood borne virus (BBV ) transmission.
Between December 2015 and February 2016, four new cases of HIV infection were diagnosed across two
male vulnerable prisoner (VP) custodial units in Wales, UK. Cases were identified through routine BBV testing.
The paper aims to discuss these issues.
Design/methodology/approach As a result of identifying four new HIV cases, targeted BBV testing
across the VP units using dried blood spot testing for HIV, Hepatitis C (HCV) and Hepatitis B was undertaken.
Findings A total of 617 men were offered testing, 256 (41 per cent) were tested. No further cases of
HIV were identified. Eight men were identified as HCV antibody positive. There was no evidence to suggest
the four original cases of HIV were linked.
Practical implications Embedding universal BBV screening within prison health provision will ensure
timely identification of cases. Further research is needed to better understand BBV transmission risks within
subsets of the prison population such as the VP and sex offending groups.
Originality/value Little is known about the prevalence of BBVs in vulnerable prison populations. The
findings add to the knowledge available for practitioners in the field.
Keywords HIV, Health in prison, Blood-borne viral infections, Hepatitis C
Paper type General review
Introduction
Prison populations worldwide are at a high risk of blood borne virus (BBV ) transmission,
including hepatitis C (HCV), hepatitis B (HBV ) and HIV (World Health Organisation, 2014). Across
the UK and Republic of Ireland prevalence estimates of HCV in the prison population vary
between 7 and 31 per cent, the higher prevalence being found in those with a history of injecting
drug use (IDU) (Allwright et al., 2000; Weild et al., 2000; Kirwan et al., 2011). HIV prevalence has
been found to be 0.40.5 per cent (Weild et al., 2000). Published UK prison prevalence figures
are several years old; European and international figures are of concern. HIV prevalence was
2.6 per cent amongst prisoners in Italy (Babudieri et al., 2015) and 2 per cent amongst prison
populations in France (Semaille et al., 2013). Globally the burden of HIV in prisons remains
concerning (Kinner et al., 2018). The prison environment is considered high risk for BBV
transmission compounded by the lack of harm reduction measures such as needle exchange
and often poor condom availability (World Health Organisation, 2014).
Whilstrates of BBVs are known to be highwithin the general prisonpopulation, littleis known about
prevalenceamongst specific subsetsof the prison populationsuch as vulnerableprisoners (VPs) or
juveniles or by offence group such as by sexual offences (Gough et al.,2010).TheUKprisonVP
population is defined as those who need protection from other prisoners fora variety of reasons,
including the nature of their offence, debt, or conflicts outside or within the prison(HMIP, 2012).
The majority of men held for sexual offences thus reside within VP units. Wales holds a prison
Received 6 March 2018
Revised 23 July 2018
10 September 2018
11 October 2018
Accepted 12 October 2018
The authors would like to thank
Heather Lewis, Consultant in
Health Protection, Public Health
Wales, Sion Lingard, Consultant in
Health Protection, Public Health
Wales, staff at the Welsh Specialist
Virology Centre, Public Health
Wales Microbiology Cardiff and
staff at the prisons concerned.
Stephanie E. Perrett and
Thomas D. Waite are both
based at Public Health Wales,
Cardiff, UK.
PAGE244
j
INTERNATIONALJOURNAL OF PRISONER HEALTH
j
VOL. 15 NO. 3 2019, pp. 244-249, © Emerald Publishing Limited, ISSN 1744-9200 DOI 10.1108/IJPH-03-2018-0010

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT